Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
CELM Inc, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%, Oct-Dec Ordinary Profit Decreases by 10%
7367 CELM,Inc. 【J-GAAP】
Earnings ReportCELM,Inc. <7367> [TSE Std] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 6.6% from the same period last year to 0.88 billion yen. The progress rate toward the full-year plan of 1.07 billion yen was 82.5%, below the four-year average of 90.7%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 3.3 times that of the same period last year, reaching 0.18 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 0.41 billion yen, a 9.6% decrease compared to the same period last year. However, the operating profit margin rose from 20.4% in the same period last year to 20.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 5,470 | 860 | 847 | 516 | 20.4 | 92.2 | Feb 10, 2023 | J-GAAP |
Apr - Dec, 2023 | 5,687 | 962 | 949 | 598 | 25.8 | 94.3 | Feb 9, 2024 | J-GAAP |
Apr - Dec, 2024 | 5,886 | 973 | 886 | 570 | 25.8 | 82.5 | Feb 10, 2025 | J-GAAP |
YoY | +3.5% | +1.1% | -6.6% | -4.7% | +0.0% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 4,074 | 535 | 517 | 341 | 14.7 | 5.50 | May 14, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 4,466 | 617 | 604 | 425 | 19.8 | 9 | Nov 12, 2024 | J-GAAP |
YoY | +9.6% | +15.3% | +16.8% | +24.6% | +34.8% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 7,265 | 936 | 919 | 542 | 21.6 | 6.50 | May 12, 2023 | J-GAAP |
Mar, 2024 | 7,504 | 1,037 | 1,006 | 631 | 27.2 | 9.50 | May 14, 2024 | J-GAAP |
Mar, 2025 Guidance | 8,008 | 1,100 | 1,074 | 720 | 33.6 | 14 | Nov 12, 2024 | J-GAAP |
YoY | +6.7% | +6.1% | +6.8% | +14.1% | +23.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 2,257 | 460 | 460 | 308 | 13.3 | 20.4 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 1,817 | 75 | 57 | 33 | 1.4 | 4.1 | May 14, 2024 | J-GAAP |
Apr - Jun, 2024 | 1,624 | 219 | 212 | 124 | 5.4 | 13.5 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,918 | 264 | 258 | 171 | 7.6 | 13.8 | Nov 12, 2024 | J-GAAP |
Oct - Dec, 2024 | 2,344 | 490 | 416 | 275 | 12.4 | 20.9 | Feb 10, 2025 | J-GAAP |
YoY | +3.9% | +6.5% | -9.6% | -10.7% | -6.3% |
Related Articles
SINANEN HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Increases by 9.6 times
MARUYAMA MFG, Oct-Dec (1Q) Ordinary Profit Loss Widens
SoftBank Corp, Apr-Dec (Cumulative 3Q) Net Income Increases by 7%
NITTO KOGYO, Oct-Dec (3Q) Ordinary Profit Increases by 17%
DAITO KOUN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%, Oct-Dec Ordinary Profit Increases by 25%
TAZMO, Last Fiscal Year Ordinary Profit Revised Upward by 33%, Raises Record High Profit Forecast
KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan
Nippon Carbon, 2% Increase in Ordinary Profit for The Current Fiscal Year
NISSAN TOKYO SALES, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 9%